• Uncategorized

Material Transfer Agreement Icmr

For the transfer (import/export) of biological samples of humans for commercial purposes, communication from the Directorate General of Foreign Trade, Ministry of Trade and Industry, GoI is to be followed – Download Notification ICMR provides guidelines for the transmission of human biology materials in accordance with the guidelines of the Ministry of Health and Family Welfare, As of 19 November 1997, a committee was established to examine cases related to the transmission of human biological material for commercial purposes and/or the assessment of cases involving transfers of infectious biological materials, human biological waste or other commercial cases from foreign research centres to Indian research centres or research centres. The communication states that, depending on the requirements, separate applications for the importation or export of biological samples should be submitted and separate applications should be made for the transfer of samples to or from different countries. A copy of the duly signed Material Transfer Agreement (MTA); The release of the Institutional or Independent Ethics Committee (IEC) and the composition of the ethics committee (if available in a foreign language, should be translated into English); a copy of the patient`s information sheet and the CIS-approved consent form based on the patient`s use for a given research or research and development study and the type of utility (direct/indirect or, if applicable, no benefit for appropriate patient decision-making (if available in a foreign language); a copy of the import certificate issued by the relevant foreign regulator to the foreign laboratory that receives Indian biological material (export-related), a copy of the economic benefits agreement for each contracting party signed between the Indian applicant and the international agency, and a separate copy of the details of intellectual property rights (if they exist) , a copyright or moU signed by one of the contracting parties regarding biological or genetic material transferred for commercial purposes. 1. The Ministry of Health and F.W. adopted a Working Memorandum No. L.20025/90-90-F. of 27 February 1992, which authorized, in certain circumstances, the limited transfer of biological material abroad for research/diagnosis purposes. The O.M.

also indicated that the Director General. The CIMR would be the starting point for clarifying all of these proposals. (vi) In order to protect the rights of Indian participants and Indian scientists/organizations, agreements should be reached between cooperation partners (Indians and foreigners) regarding communication and/or equipment transfer agreements. These elements should include, in accordance with the requirements of the case, elements related to the identification of the collaborating or issuing/receptive parties, context, material to be transferred and quantities, research to be carried out, underutilization of material, confidentiality, intellectual property rights, respect for intellectual property rights, patent enforcement, rules relating to future commercial exploitation, reporting, publication rights, compensation, termination of contract, transfer or transfer of rights; Safety standards, shipping agreements. Qualified user information and any other issues that may be relevant to the exchange of relevant material. Guidelines for the transfer of human biological material for research/commercial use (iv) The availability of facilities in India to conduct certain studies should not prevent cooperation with scientists from other countries for the same studies, including, if necessary, the transmission of human material.

Dr. Avery Jenkins

Dr. Avery Jenkins is a chiropractic primary care physician in Litchfield, CT. He is board certified in clinical nutrition and acupuncture, and is a frequent speaker and lecturer. He provides drug testing services for employers, courts, and attorneys state-wide.

You may also like...